Publications

Publications

List of all Publications

  • Mitra A, Yadav A, Mehta N, Varma V, Kumaran V, Nundy S. Complicated perianal sepsis. Indian J Surgery. Indian J Surg. 2015 Dec;77(Suppl 3):769-73.
  • Sirohi B, Barreto SG, Singh A, Batra S, Mitra A, Rastogi S, Ramadwar M, Shetty N, Goel M, Shrikhande SV. Epirubicin, oxaliplatin, and capectabine is just as "MAGIC"al as epirubicin, cisplatin, and fluorouracil perioperative chemotherapy for resectable locally advanced gastro-oesophageal cancer. J Cancer Res Ther. 2014 Oct-Dec;10(4):866-70.
  • Sirohi B, Mitra A, Jagannath P, Singh A, Ramadvar M, Kulkarni S, Goel M, Shrikhande SV. Neoadjuvant chemotherapy in patients with locally advanced gallbladder cancer. Future Oncol. 2015 May;11(10):1501-9.
  • Mitra A, De’souza A, Goel M, Shrikhande SV. Surgery for pancreatic and periampullary carcinoma. Indian Journal of Surgery. 2015 Oct;77(5):371- 80.
  •  Mitra A, Shrikhande SV, Sirohi B. Histopathological regression after taxane based neoadjuvant chemotherapy in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma. Transl Gastroenterol Hepatol. 2017 May 16;2:46.
  • van Rijssen LB, Gerritsen A, Henselmans I, Sprangers MA, Jacobs M, Bassi C, Busch OR, Fernández-Del Castillo C, Fong ZV, He J, Jang JY, Javed AA, Kim SW, Maggino L, Mitra A, Ostwal V, Pellegrini S, Shrikhande SV, Wilmink JW, Wolfgang CL, van Laarhoven HW, Besselink MG; COPRAC study group. Core Set of Patient-reported Outcomes in Pancreatic Cancer (COPRAC): An International Delphi Study Among Patients and Health Care Providers. Ann Surg. 2017 Dec 19. doi: 10.1097/SLA.0000000000002633.
  • Mitra A, Pai E, Dusane R, Ranganathan P, DeSouza A, Goel M, Shrikhande SV. Extended pancreatectomy as defined by the ISGPS: useful in selected cases of pancreatic cancer but invaluable in other complex pancreatic tumors. Langenbecks Arch Surg. 2018 Mar;403(2):203-212. doi: 10.1007/s00423-018-1653-6.
  • Agarwal V, Thomas MJ, Joshi R, Chaudhari V, Bhandare M, Mitra A, deSouza A, Ambulkar R, Shrikhande SV. Improved Outcomes in 394 Pancreatic Cancer Resections: the Impact of Enhanced Recovery Pathway. J Gastrointest Surg. 2018 Oct;22(10):1732-1742. doi:10.1007/s11605-018-3809-7.
  • Shinde R, Bhamre R, Niyogi D, Mitra A, Desouza A, Ostwal V, Engineer R, Dusane R, Saklani A. Does histology dictate outcomes of locally advanced rectal adenocarcinoma with complete pathological response following neoadjuvant chemoradiation? J Radiat Oncol (2018) 7: 85. https://doi.org/10.1007/s13566-017-0341-4.
  • Bhambre R, Mitra A, Tamankar A, Desouza A, Saklani A. Impact of Length of Distal Margin on Outcomes Following Sphincter Preserving Surgery for Middle and Lower Third Rectal Cancers. Accepted in Indian Journal of Surgical Oncology.
  • Mitra A, Mehta N, Varma V, Kumaran V, Nundy S. Current management of colorectal liver metastases: A perspective. The Ganga Ram Journal 2011;1:247–253.
  • Mitra A, Sirohi B, Shrikhande SV. Neoadjuvant therapy in pancreatic cancer. Current Medicine Research and Practice (2014), http://dx.doi.org/10.1016/j.cmrp.2014.03.002.
  • Mitra A, Shrikhande SV. Commentary on Neoadjuvant treatment of borderline resectable and non-resectable pancreatic cancer. Annals of surgical oncology 2013. Pancreatic cancer India website.
  •  Shrikhande SV, Batra S, Mitra A, Patkar S, Goel M. Neuroendocrine Tumors of Pancreas. G.I. Surgery Annual. Volume 21.2014
  • Mitra A, Sirohi B, Goel M, Shrikhande SV. Borderline resectable pancreatic cancer. Evidence-Based Practices in Gastrointestinal, Colorectal and Hepatobiliary Surgery. Jaypee publishers, 2017. doi: 10.5005/jp/books/1302
  • Sinukumar S, Mitra A, Shrikhande SV. Puzzling cases- 2 pancreatic cases.
  • Sirohi B, Mitra A, Shrikhande SV. Impact of chemoradiotherapy on postoperative complications in GI surgery.
  • Shrikhande SV, Mitra A. Borderline resectable pancreatic cancer- What can we expect in the next 10 years. Pancreatology the next decade. November 21, 2014
  • Mitra A, Chattopadhyaya S, Varma V, Mehta N, Kumaran V, Nundy S. Effect of preoperative biliary stenting on outcome of pancreaticoduodenectomy. Trop Gastroenterol 2011;32(Suppl 3):S94-5.
  • Mitra A, Kumaran V, Mehta N, Varma V, Nundy S. Factors determining outcome after hepatectomy for malignancies. Trop Gastroenterol 2011;32(Suppl 3):S57.
  • Mitra A, Ghuman SS, Rawat KS, Mehta N, Varma V, Nundy S, Kumaran V. Estimation of Graft Weight Using Computed Tomography Volumetry in Living Donor Liver Transplantation. Liver Transplantation.
  • Mitra A, Ghuman SS, Rawat KS, Mehta N, Varma V, Nundy S, Kumaran V. Estimation of Graft Weight Using Computed Tomography Volumetry in Living Donor Liver Transplantation. Trop Gastroenterol 2012;33(Suppl 1):S58.
  • Mitra A, Reena Engineer, Bhawna Sirohi, Nitin Shetty, Mahesh Goel, Shailesh V Shrikhande. Borderline resectable pancreatic tumors: the role of multimodality management. Pancreatology 14 (2014) S1-S10. Poster presentation at AOPA 2014, New Delhi.
  • Shrikhande SV, Mitra A, Sirohi B, Goel M. Pancreaticoduodenectomy (PD) for periampullary tumors: Results from Tata Memorial Centre (TMC) over two decades. Poster presented at ASCO
  • Goel M, Mitra A, Patkar S, Shrikhande SV. Incidental carcinoma of gallbladder-evidence for redefining revision surgery. Poster presented at Japanese HPB conference.
  • Mitra A, Shetty N, Patkar S, Ostwal V, Engineer R, Goel M, Shrikhande SV. Borderline Resectable Pancreatic Tumors: Multimodal Approach Improves Outcomes. Poster presentation at APHPBA 2015, Singapore
  • Goel M, Mitra A, Patkar S, Shrikhande SV. 176 Liver Resections: Experience from Tata Memorial Centre. Poster presentation at APHPBA 2015, Singapore
  • Mitra A, Patkar S, Desouza A, Goel M, Shrikhande SV. 860 consecutive Pancreaticoduodenectomies at Tata Memorial Centre: trend over more than 2 decades. HPB 2016, 18 (S1), e385ee601.
  • Goel M , Patkar S, Bhandare M, Chaudhari V, Mitra A , DeSouza A, Shrikhande SV. Outcomes Following Surgical Resection of 515 Patients with Gall Bladder Cancer: Indian Experience. HPB 2016, 18 (S1), e1ee384.
  • Chaudhari V, Bhandare M, Patkar S, Mitra A, Desouza A, Ostwal V, Sirohi B, Shrikhande SV, Goel M. Neoadjuvant Chemotherapy In Gallbladder Cancer- Outcome of 112 Patients from Tata Memorial Centre. HPB 2016, 18 (S1), e1ee384.
  • Patkar S, Goel M, Patil S, Shetty N, Chaudhari V, Bhandare M, Mitra A, Ostwal V, Sirohi B, Desouza A and Shrikhande SV. Liver Directed Therapies in Management of Colorectal Liver Metastasis (CRLM): Experience from Tata Memorial Centre. HPB 2016, 18 (S1), e1ee384.
  • Joshi R, Thomas MJ, Bansode R, Mitra A, Chaudhari V, Desouza A, Singh V, Ambulkar R, Goel M, Shrikhande S, Agarwal V. Hepatic Resections and Enhanced Recovery Pathway: an Indian Encounter. Clinical Nutrition ESPEN 12 (2016) e30ee59.
  • Actively conducted speciality “Pancreas clinic” as a Lecturer at Tata
    Memorial Hospital.
  • Maintained “organ specific databases” for liver, gallbladder and pancreatic
    surgeries
  • Conducted “interactive sessions” as faculty with GIST patients and
    caregivers in collaboration with Max Foundation at Tata Memorial Hospital,
    Mumbai
  • Involved in “teaching and training” of M.ch registrars and Nurses at Tata
    Memorial Hospital, Mumbai and later at NCI Nagpur.